SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Shaman Pharmaceuticals has been moving on big, relative,
SHMN 0.001000-16.7%Jan 15 10:27 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Daniel Shaffer who wrote (821)4/20/2001 2:13:28 PM
From: JMarcus  Read Replies (2) of 838
 
NSF isn't on the shelves at GNC yet. Shaman believes it could be another 30-60 days.

One of Shaman's biggest assets is its tax losses. I've heard that bankruptcy law can make it somewhat easier for those to be transferred to a company that purchases substantially all of the business. I expect that Shaman will try to sell the NSF business to a company that needs the tax losses and that the deal will be structured in such a way as to allow the purchaser to utilize those tax losses. I think Shaman would like to retain some of its R&D projects.

I think there's still a good chance that something will be salvaged for the stockholders, but it is far from a sure thing.

Marc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext